clarithromycin
Commercial- Indications
- Bacterial infections
Company intelligence / Profile preview
Kangmei Pharmaceutical has a broad commercial portfolio focused on traditional Chinese medicines and generic pharmaceuticals. It has several well-known over-the-counter remedies for colds/flu and immune support. The company also markets chemical generics such as clarithromycin and doxazosin mesylate. In recent years it has developed or distributed drugs for oncology indications using both TCM approaches and conventional medicines. The company was embroiled in a major financial fraud scandal in the late 2010s but continues to operate with government intervention.[6] Clinical trial activity appears limited compared to its commercial operations.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kangmei Pharmaceutical.